Submit Deal

HOBA THERAPEUTICS

Summary

Hoba Therapeutics, a Novo Holdings-founded Danish biotech company dedicated to developing novel therapeutic proteins for patients living with chronic neuropathic pain and hearing loss

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 20 M

Avg. Deal Size£ 20 M

Market Context

Senior Management

Torsten M. Madsen
CEO

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy